Long-Term Follow-up of Phase II Study of Chemotherapy Plus Dasatinib for the Initial Treatment of Patients with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia

類似資料

• First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome–positive (Ph(+)) acute lymphoblastic leukemia
  著者:: Ravandi, Farhad, 等
  出版事項: (2010)
• Phase II trial of HyperCVAD and Dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia
  著者:: Benjamini, Ohad, 等
  出版事項: (2014)
• Clofarabine Combinations as Acute Myeloid Leukemia Salvage Therapy
  著者:: Faderl, Stefan, 等
  出版事項: (2008)
• Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis
  著者:: Verstovsek, Srdan, 等
  出版事項: (2008)
• A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
  著者:: Faderl, Stefan, 等
  出版事項: (2008)